| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/13/2013 | CN102154307B Method for preparing recombinant chicken beta-interferon and application thereof |
| 03/13/2013 | CN102138909B Asparaginase freeze-dried powder injection and preparation method thereof, as well as asparaginase solution |
| 03/13/2013 | CN102127549B Chicken antimicrobial peptides Cathelicidins and preparation method and applications thereof |
| 03/13/2013 | CN102093993B Kringle 5 mutant protein, and preparation method and application thereof |
| 03/13/2013 | CN102085371B Medical gargle product for Xerostomia and preparation method thereof |
| 03/13/2013 | CN102056630B Stabilizer for lymph vessel |
| 03/13/2013 | CN102048694B Polypeptide-modified liver tumor-targeted nano medicine delivery system and preparation method thereof |
| 03/13/2013 | CN102046169B Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates |
| 03/13/2013 | CN101961486B 一种滴眼液及其制备方法 One kind of eye drops and its preparation method |
| 03/13/2013 | CN101897948B Application of S-nitroso glutathione |
| 03/13/2013 | CN101851278B B cell activating factor antagonist as well as preparation method and application thereof |
| 03/13/2013 | CN101747410B Aminoacyl tyrosyl tryptophan tripeptide with easing pain activity and preparation method and application thereof |
| 03/13/2013 | CN101633636B Peptidomimetic protease inhibitors |
| 03/13/2013 | CN101597335B Recombined protein specially combined with fiber protein and application thereof |
| 03/13/2013 | CN101553985B A/D converter, A/D converting method, A/D converting control apparatus |
| 03/13/2013 | CN101528772B Metastin衍生物及其用途 Metastin derivatives and their use |
| 03/13/2013 | CN101511391B N-terminal polysialylation |
| 03/13/2013 | CN101417124B Biocompatible material and process for manufacturing the same |
| 03/13/2013 | CN101395173B Template-fixed peptidomimetics with antimicrobial activity |
| 03/13/2013 | CN101384716B HLA-a*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 03/13/2013 | CN101378773B Stable protein formulations |
| 03/13/2013 | CN101351220B Thrombin-free biological adhesive and use thereof as a medicament |
| 03/13/2013 | CN101302256B Novel recombinant fusion molecule and antineoplastic treatment function thereof |
| 03/13/2013 | CN101291686B Activated factor X(FXa) stimulants as new antihemorrhagic agents for topical use |
| 03/13/2013 | CN101228169B Macrocyclic inhibitors of hepatitis c virus |
| 03/13/2013 | CN101142232B KUNITZ-type recombinant inhibitor |
| 03/13/2013 | CN101134779B Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/12/2013 | US8394933 Protein refolding column filler and column |
| 03/12/2013 | US8394932 Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394929 Nogo receptor-mediated blockade of axonal growth |
| 03/12/2013 | US8394924 Directed engagement of activating Fc receptors |
| 03/12/2013 | US8394921 N-terminal derivatisation of proteins with polysaccharides |
| 03/12/2013 | US8394847 Methods of treating an inflammatory-related disease |
| 03/12/2013 | US8394777 Treating immunodeficiencies by intrathymic injection of nucleotide sequences |
| 03/12/2013 | US8394771 Multimeric proteins and methods of making and using same |
| 03/12/2013 | US8394770 Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats |
| 03/12/2013 | US8394769 Anti-hypertensive agent |
| 03/12/2013 | US8394768 Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentrates |
| 03/12/2013 | US8394767 Methods of treating cancer using the calcitonin-gene related peptide (“CGRP”) receptor antagonist CGRP8-37 |
| 03/12/2013 | US8394766 Cellular activation insulin therapy |
| 03/12/2013 | US8394765 Administering mixture of amylin and leptin, or antagonist thereof |
| 03/12/2013 | US8394764 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 03/12/2013 | US8394763 Cyclic undecapeptides and derivatives as multiple sclerosis therapies |
| 03/12/2013 | US8394761 Methods for treating congestive heart failure |
| 03/12/2013 | US8394759 Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes |
| 03/12/2013 | US8394758 Tumor-targeting peptides and uses thereof |
| 03/12/2013 | US8394757 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 03/12/2013 | US8394756 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells |
| 03/12/2013 | US8394628 RNA sequence-specific mediators of RNA interference |
| 03/12/2013 | US8394418 Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| 03/12/2013 | US8394414 Synthetic biodegradable microparticles incorporating a therapeutic, prophylactic or diagnostic agent having a diameter of 0.5-10 microns and release the agent at a pH of 6.0 or greater |
| 03/12/2013 | US8394390 Neisserial antigenic peptides |
| 03/12/2013 | US8394387 Recombinant modified Bacillus anthracis protective antigen for use in vaccines |
| 03/12/2013 | US8394384 Recombinant avian influenza vaccine and uses thereof |
| 03/12/2013 | US8394382 Siglec-9 Binding Agents |
| 03/12/2013 | US8394373 Disintegrin and metalloproteinase containing thrombospondin 1-like domains (ADAMTS); ADAMTS13 protease and to nucleic acids encoding ADAMTS13 proteases; von Willebrand bactor cleaving protease activity; treating acquired thrombotic thrombocytopenic purpura; anticoagulant drug development |
| 03/12/2013 | US8394372 Stabilized protease composition |
| 03/12/2013 | US8394371 Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
| 03/12/2013 | US8394368 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 03/12/2013 | US8394367 IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy |
| 03/12/2013 | US8394362 Gem difluorinated C-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosugery |
| 03/12/2013 | US8394141 Connective-tissue-based or dermal-tissue-based grafts/implants |
| 03/12/2013 | CA2727803C Metal abstraction peptide (map) tag and associated methods |
| 03/12/2013 | CA2711709C Oral care compositions containing ovomucin |
| 03/12/2013 | CA2680946C Pim-3 kinase as a target for type 2 diabetes mellitus |
| 03/12/2013 | CA2619779C Use of a pde5 inhibitor for treating and preventing hypopigmentary disorders |
| 03/12/2013 | CA2550085C Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 03/12/2013 | CA2542332C Immunomodulating compositions and uses therefor |
| 03/12/2013 | CA2538904C Glutamine for use in treating injury |
| 03/12/2013 | CA2517077C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/12/2013 | CA2480199C Fp-ghrelin |
| 03/12/2013 | CA2473927C Methods and compositions for treating polycystic ovary syndrome |
| 03/12/2013 | CA2469685C Bispecific antisense oligonucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same |
| 03/12/2013 | CA2468888C Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2454421C Use of long pentraxin ptx3 for treating female infertility |
| 03/12/2013 | CA2453561C Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 03/12/2013 | CA2416877C Somatic cloning gene transfer for producing recombinant proteins, cells and organs |
| 03/12/2013 | CA2369908C Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof |
| 03/12/2013 | CA2288218C Novel differentiation-inhibitor |
| 03/07/2013 | WO2013033717A1 Enzyme responsive nanocapsules for protein delivery |
| 03/07/2013 | WO2013033675A1 Chimeric natriuretic peptide compositions and methods of preparation |
| 03/07/2013 | WO2013033645A1 Thioether-,ether-, and alkylamine-linked hydrogen bond surrogate pertidomimentics |
| 03/07/2013 | WO2013033636A2 Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same |
| 03/07/2013 | WO2013033561A1 Vegf-specific capture agents, compositions and methods of using and making |
| 03/07/2013 | WO2013033518A1 Methods for treating properdin-related diseases or disorders |
| 03/07/2013 | WO2013033459A2 Compositions, methods and uses for peptides in diagnosis, progression and treatment of cancers |
| 03/07/2013 | WO2013033452A2 Method of treating or ameliorating type 1 diabetes using fgf21 |
| 03/07/2013 | WO2013033420A1 Methods of downregulating translocated oncogene expression using bromodomain inhibitors |
| 03/07/2013 | WO2013033395A1 MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE |
| 03/07/2013 | WO2013033283A1 Improving systemic glucose tolerance in type-2 diabetes |
| 03/07/2013 | WO2013032948A1 Method for inhibiting cellular activation by insulin-like growth factor-1 |
| 03/07/2013 | WO2013032853A1 Activators of cxcr3 for the treatment of angiopathies of the eye |
| 03/07/2013 | WO2013032828A2 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 03/07/2013 | WO2013032784A1 Natriuretic polypeptides |
| 03/07/2013 | WO2013032411A1 Silk-based bioactive oligopeptide compositions and manufacturing process therefor |
| 03/07/2013 | WO2013032248A2 Composition for improving skin conditions, containing extracellular domain of human bone morphogenetic protein receptor 1a as active ingredient |
| 03/07/2013 | WO2013032210A2 Biomembrane permeable composition |
| 03/07/2013 | WO2013032028A1 New compound material, medicine containing same, and cancer treatment method using same |